Zealand Pharma A/S (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,700 | 977,288 | 1,070,224 | 1,100,954 | -47,317 |
| Depreciation Amortization | N/A | 4,144 | N/A | 1,851 | 841 |
| Accounts receivable | N/A | -13,363 | N/A | -22,366 | -621 |
| Accounts payable and accrued liabilities | N/A | -27,000 | N/A | -716 | -1,478 |
| Other Working Capital | -43,848 | -55,084 | -68,501 | -41,497 | -25,299 |
| Other Operating Activity | 313 | 102,950 | 184,483 | 181,392 | 3,213 |
| Operating Cash Flow | $-105,235 | $988,935 | $1,186,206 | $1,219,618 | $-70,662 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,443 | -333,543 | -294,338 | -156,324 | 79,492 |
| PPE Investments | -1,566 | -1,475 | -2,587 | -1,959 | -911 |
| Purchase Sale Intangibles | -157 | -5,406 | -409 | -398 | -325 |
| Other Investing Activity | -157 | -5,406 | 3,291 | 3,196 | -325 |
| Investing Cash Flow | $-18,166 | $-340,424 | $-293,635 | $-155,087 | $78,257 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 157 | 7,441 | 5,094 | 4,659 | 500 |
| Common Stock Repurchased | N/A | -61,646 | -63,763 | -50,559 | N/A |
| Other Financing Activity | -1,409 | -3,053 | -2,221 | -1,333 | -612 |
| Financing Cash Flow | $-1,253 | $-57,257 | $-60,889 | $-47,233 | $-112 |
| Exchange Rate Effect | 10,649 | -8,287 | -10,052 | -25,908 | -412 |
| Beginning Cash Position | 716,758 | 109,921 | 113,697 | 110,430 | 102,443 |
| End Cash Position | 602,753 | 692,888 | 935,327 | 1,101,820 | 109,515 |
| Net Cash Flow | $-114,005 | $582,967 | $821,630 | $991,390 | $7,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -105,235 | 988,935 | 1,186,206 | 1,219,618 | -70,662 |
| Capital Expenditure | -1,566 | -5,052 | -2,587 | -1,959 | -911 |
| Free Cash Flow | -106,801 | 983,883 | 1,183,619 | 1,217,659 | -71,572 |